What Diseases Is Apitherapy Used For? A Scientific Evidence Overview
Apitherapy is a therapeutic approach that uses products derived from the beehive—such as honey, propolis, pollen, royal jelly, and bee venom—for health-related purposes. In recent years, growing scientific interest has focused on the biological properties of these natural substances. A number of experimental and clinical studies have explored the potential benefits of apitherapy in inflammatory, metabolic, respiratory, and musculoskeletal diseases, largely due to the presence of bioactive compounds with anti-inflammatory, antimicrobial, antioxidant, and immunomodulatory effects. Although apitherapy does not replace conventional medical treatment, emerging evidence suggests that it may play a role as a complementary therapeutic approach in certain conditions when used under appropriate medical supervision.
Scientific interest in apitherapy has expanded significantly over the past decade. Researchers have investigated the biological activity of several bee-derived products, particularly bee venom, propolis, and medicinal honey. These substances contain a wide range of bioactive molecules—including peptides such as melittin, flavonoids, phenolic compounds, and antimicrobial peptides—that may influence key physiological processes such as inflammation, immune regulation, oxidative stress, and tissue repair. As a result, apitherapy has been increasingly studied in a variety of medical contexts, ranging from musculoskeletal disorders and chronic pain to respiratory, metabolic, and gastrointestinal diseases.
Given this growing body of research, many people are asking what diseases apitherapy may be used for and what the scientific evidence actually shows. While some studies report promising therapeutic effects, current evidence varies depending on the disease being studied, the specific bee product used, and the treatment protocol applied. In the following sections, we review the main medical conditions in which apitherapy has been investigated, including osteoarticular disorders, respiratory diseases, metabolic conditions such as diabetes and dyslipidemia, and gastrointestinal disorders. Understanding the current scientific evidence helps clarify both the potential benefits and the limitations of apitherapy in modern integrative medicine.
What diseases is apitherapy used for?
Apitherapy is a therapeutic approach within integrative medicine that uses bee-derived products—such as honey, propolis, pollen, royal jelly, and bee venom—for preventive and complementary health purposes. In recent years, scientific research has increasingly focused on the biological effects of these natural substances, particularly because they contain bioactive compounds with anti-inflammatory, antimicrobial, antioxidant, and immunomodulatory properties. Due to these characteristics, apitherapy has attracted growing interest in both natural medicine and biomedical research.
A variety of studies have investigated the potential use of apitherapy across different medical fields. In particular, apitherapy has been explored in osteoarticular diseases such as osteoarthritis and rheumatoid arthritis, where bee-derived products may contribute to the modulation of inflammation and pain. Likewise, apitherapy has also been studied in musculoskeletal disorders and chronic pain conditions, largely because certain components of bee venom may have analgesic and anti-inflammatory effects.
Scientific investigations have also examined the possible role of apitherapy in metabolic, respiratory, and digestive diseases. Experimental and clinical studies have evaluated whether apitherapy may have beneficial effects in conditions such as diabetes, dyslipidemia, asthma, chronic respiratory diseases, and gastrointestinal disorders. In many of these contexts, bee products have demonstrated biologically relevant activity, encouraging further research within the field of integrative medicine.
However, it is important to emphasize that although apitherapy shows promising findings in several areas of research, scientific evidence is still evolving for many of these conditions. For this reason, apitherapy is currently considered a complementary therapeutic approach, which may be integrated with conventional medical treatment under professional supervision. Understanding what diseases apitherapy is used for and the current state of scientific evidence helps provide a balanced perspective on its potential role in modern healthcare.
Osteoarticular diseases
Osteoarticular diseases represent one of the medical fields in which apitherapy has been most extensively investigated within integrative medicine. These conditions are primarily characterized by chronic inflammation, joint pain, and progressive deterioration of joint structures. Because several bee-derived products contain compounds with anti-inflammatory and immunomodulatory properties, apitherapy has attracted attention as a potential complementary therapy in the management of these disorders.
In particular, apitherapy has been studied in diseases such as osteoarthritis and rheumatoid arthritis, two of the leading causes of joint pain and disability worldwide. Experimental and clinical studies suggest that certain components of bee venom—especially melittin—may influence inflammatory mediators involved in joint damage. Through these mechanisms, apitherapy may potentially contribute to reducing inflammation, alleviating pain, and improving joint function when used as part of a comprehensive therapeutic approach.
In addition to bee venom, other products used in apitherapy, including propolis and honey, have also been investigated for their antioxidant and anti-inflammatory properties. These biological activities may be particularly relevant in osteoarticular diseases where oxidative stress and chronic inflammation play a key role in disease progression. As a result, apitherapy continues to be explored as a complementary strategy in degenerative and autoimmune joint disorders.
In the following sections, we will examine in greater detail how apitherapy has been studied specifically in two major osteoarticular conditions: osteoarthritis and rheumatoid arthritis.
| Disease | Disease type | Potential role of apitherapy |
|---|---|---|
| Osteoarthritis | Degenerative | Possible reduction of joint inflammation and pain |
| Rheumatoid arthritis | Autoimmune | Modulation of inflammatory pathways |
| Systemic lupus erythematosus | Autoimmune | Potential immunomodulatory effects under investigation |
| Ankylosing spondylitis | Autoimmune inflammatory | Possible anti-inflammatory effects |
| Fibromyalgia | Chronic pain syndrome | Potential analgesic and neuromodulatory effects |
| Gout | Metabolic inflammatory disease | Possible anti-inflammatory action during joint inflammation |
| Tendinitis | Overuse inflammatory condition | Potential reduction of local inflammation |
| Bursitis | Inflammatory | Possible relief of pain and inflammation |
Chronic pain and musculoskeletal disorders
Chronic pain is one of the most common health problems worldwide and is associated with a significant reduction in quality of life, functional limitations, and increased healthcare utilization. In this context, apitherapy has been investigated as a potential complementary approach for managing different forms of chronic pain, particularly those related to musculoskeletal disorders. The presence of bioactive compounds in bee-derived products, especially bee venom, has attracted attention because of their potential anti-inflammatory and analgesic effects.
Several experimental and clinical studies have evaluated apitherapy in patients with persistent musculoskeletal pain, including chronic low back pain, myofascial pain syndrome, and other conditions related to soft tissue overuse or injury. Some researchers suggest that certain components of bee venom may influence neuroinflammatory mediators and pathways involved in pain perception. Through these mechanisms, apitherapy may potentially contribute to reducing pain intensity and improving mobility in certain patients.
In addition to bee venom, other products used in apitherapy, such as propolis and honey, have also been investigated for their antioxidant and anti-inflammatory activity. These biological effects may be relevant in chronic inflammatory processes affecting muscles, tendons, and periarticular tissues. For this reason, apitherapy continues to be explored in integrative medicine as a complementary strategy for the management of chronic musculoskeletal pain.
| Condition | Disorder type | Potential role of apitherapy |
|---|---|---|
| Chronic low back pain | Musculoskeletal pain | Possible analgesic and anti-inflammatory effects |
| Myofascial pain syndrome | Chronic muscular pain | Potential reduction of trigger point pain |
| Chronic neck pain | Musculoskeletal | Possible improvement in pain and mobility |
| Tendinitis | Overuse inflammatory condition | Reduction of local inflammation |
| Bursitis | Inflammatory | Possible relief of periarticular pain |
| Overuse injuries | Musculoskeletal | Potential anti-inflammatory effects |
| Chronic muscle spasm | Neuromuscular | Possible modulation of muscle pain |
Neurological diseases
Neurological diseases represent an area of growing scientific interest in apitherapy, particularly due to the potential anti-inflammatory and neuroprotective effects of certain compounds found in bee venom. Bioactive peptides such as melittin have been studied in experimental models to understand their influence on neuroinflammatory processes within the central nervous system. These mechanisms have led researchers to explore whether apitherapy could play a role in neurological disorders characterized by inflammation, immune dysregulation, or neuronal degeneration.
One of the neurological conditions most frequently studied in relation to apitherapy is Parkinson’s disease. Experimental studies have suggested that certain components of bee venom may influence neuroinflammatory pathways and support the survival of dopaminergic neurons, which are progressively lost in this disorder. Although these findings have generated scientific interest, clinical evidence remains limited and further research is necessary to determine the real therapeutic potential of apitherapy in Parkinson’s disease.
Apitherapy has also been investigated in autoimmune neurological disorders such as multiple sclerosis. Some experimental studies suggest that bee venom components may modulate immune responses and reduce inflammatory processes associated with demyelination. However, clinical results have been heterogeneous, and therefore apitherapy is currently considered an investigational complementary approach within neurological research.
In addition to these conditions, researchers have explored the potential use of apitherapy in other neurological disorders involving neuropathic pain or inflammatory processes affecting the nervous system. While preliminary findings are promising, current scientific evidence remains limited, and more robust clinical studies are required to confirm the potential benefits of apitherapy in neurological diseases.
| Disease | Disease type | Potential role of apitherapy |
|---|---|---|
| Parkinson’s disease | Neurodegenerative | Possible neuroprotective and anti-inflammatory effects |
| Multiple sclerosis | Autoimmune demyelinating disease | Potential modulation of immune response |
| Peripheral neuropathy | Neurological | Possible analgesic and anti-inflammatory effects |
| Neuralgia | Neuropathic pain | Potential modulation of pain pathways |
| Migraine | Neurological | Possible influence on inflammatory mediators |
| Chronic neuropathic pain | Neurological | Potential reduction of pain perception |
Respiratory diseases
Respiratory diseases represent another field in which apitherapy has attracted interest within natural and integrative medicine research. Several bee-derived products—particularly propolis and honey—contain compounds with antimicrobial, anti-inflammatory, and antioxidant properties that may influence processes related to respiratory infections and airway inflammation. Because of these biological characteristics, apitherapy has been explored as a potential complementary approach in certain pulmonary diseases.
One respiratory condition in which apitherapy has been investigated is bronchial asthma. This disease is characterized by chronic airway inflammation, bronchial hyperresponsiveness, and recurrent episodes of breathing difficulty. Experimental studies suggest that certain compounds present in propolis and other bee products used in apitherapy may influence inflammatory mediators involved in the pathophysiology of asthma. However, current clinical evidence remains limited, and larger studies are required to establish definitive conclusions.
Apitherapy has also been studied in chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD). In this context, researchers have mainly explored the antioxidant and anti-inflammatory properties of products such as propolis and honey, which may help reduce inflammatory processes associated with chronic lung damage. Additionally, several studies have evaluated bee products in respiratory infections due to their antimicrobial activity against various microorganisms.
Overall, these findings suggest that apitherapy may have a potential supportive role in the management of certain respiratory diseases. Nevertheless, the available scientific evidence remains limited and heterogeneous, and therefore apitherapy is currently considered a complementary approach that should be integrated within comprehensive medical care.
| Disease | Disease type | Potential role of apitherapy |
|---|---|---|
| Bronchial asthma | Chronic inflammatory | Possible modulation of inflammatory mediators |
| Chronic obstructive pulmonary disease (COPD) | Chronic respiratory | Potential antioxidant and anti-inflammatory effects |
| Chronic bronchitis | Inflammatory | Possible reduction of airway inflammation |
| Respiratory infections | Infectious | Antimicrobial properties of propolis and honey |
| Pharyngitis and laryngitis | Inflammatory/infectious | Potential anti-inflammatory and antimicrobial effects |
Metabolic diseases (diabetes, cholesterol, and obesity)
Metabolic diseases are among the most prevalent health problems worldwide and include conditions such as type 2 diabetes mellitus, dyslipidemia, and obesity. In recent years, apitherapy has attracted scientific interest due to the potential metabolic effects of several bee products, including honey, propolis, and royal jelly. These natural products contain bioactive compounds—such as flavonoids, phenolic acids, and peptides—that may influence processes related to inflammation, glucose metabolism, and lipid metabolism.
One of the most studied areas of apitherapy is its potential role in diabetes mellitus. Several experimental and clinical studies have evaluated the effects of propolis, honey, and royal jelly on glucose metabolism and insulin sensitivity. Some preliminary findings suggest that certain compounds present in bee products may help improve metabolic parameters such as fasting glucose levels and markers of oxidative stress. However, the available scientific evidence remains heterogeneous, and apitherapy cannot be considered a substitute for conventional diabetes treatments.
Another relevant area of research is dyslipidemia, particularly elevated cholesterol and triglyceride levels. Several studies have explored the potential effect of propolis and royal jelly on lipid profiles. Some results indicate that these bee products may contribute to reductions in total cholesterol or LDL cholesterol, likely due to their antioxidant and anti-inflammatory properties. These findings have led researchers to consider apitherapy as a possible complementary strategy within metabolic and cardiovascular risk management.
Apitherapy has also been investigated in the context of obesity and metabolic syndrome. Experimental studies suggest that certain compounds present in bee products may influence energy metabolism, systemic inflammation, and oxidative stress—factors that play an important role in the development of metabolic disorders. Nevertheless, more robust clinical trials are needed to confirm the real impact of apitherapy on weight control and metabolic syndrome management.
| Disease | Disease type | Potential role of apitherapy |
|---|---|---|
| Type 2 diabetes mellitus | Metabolic | Possible influence on glucose metabolism |
| Dyslipidemia (high cholesterol) | Metabolic | Potential improvement of lipid profile |
| Hypertriglyceridemia | Metabolic | Possible reduction of triglycerides |
| Obesity | Metabolic | Possible influence on energy metabolism |
| Metabolic syndrome | Metabolic | Potential anti-inflammatory and antioxidant effects |
Digestive diseases
Digestive diseases are a common reason for medical consultation and include a wide range of conditions such as inflammatory disorders, gastrointestinal infections, and functional disturbances of the digestive tract. In this context, apitherapy has been investigated due to the biological properties of several bee products, particularly honey and propolis, which contain compounds with antioxidant, anti-inflammatory, and antimicrobial activity.
One of the most studied areas related to apitherapy is gastritis and other inflammatory diseases of the stomach. Several studies have evaluated the potential protective effects of honey on the gastric mucosa, suggesting that certain bioactive compounds may help reduce inflammation and promote repair processes in the gastrointestinal epithelium. These properties have encouraged researchers to explore the possible role of apitherapy as a complementary approach in the management of digestive disorders characterized by mucosal irritation or inflammation.
Apitherapy has also been investigated in relation to Helicobacter pylori infection, one of the most common causes of chronic gastritis and peptic ulcer disease. Experimental studies have shown that propolis may exhibit antimicrobial activity against various microorganisms, including H. pylori. Although these findings are promising, clinical studies remain limited, and further research is required to determine the real clinical role of apitherapy in managing this infection.
In addition to gastric disorders, researchers have explored the potential use of apitherapy in other digestive diseases such as irritable bowel syndrome and certain inflammatory bowel diseases. In these conditions, the antioxidant and anti-inflammatory compounds present in bee products may influence inflammatory processes in the digestive tract. Nevertheless, current scientific evidence remains preliminary, and apitherapy should be considered only as a complementary approach within comprehensive medical care.
| Disease | Disease type | Potential role of apitherapy |
|---|---|---|
| Gastritis | Inflammatory | Possible protective effect on gastric mucosa |
| Helicobacter pylori infection | Infectious | Potential antimicrobial activity of propolis |
| Gastroesophageal reflux disease | Functional/inflammatory | Possible mucosal protective effect |
| Irritable bowel syndrome | Functional disorder | Possible modulation of inflammatory processes |
| Inflammatory bowel disease | Inflammatory | Potential antioxidant and anti-inflammatory effects |
| Gastric ulcer | Inflammatory | Possible support for mucosal repair |
Cancer and apitherapy: what scientific research suggests
Cancer remains one of the leading causes of morbidity and mortality worldwide, prompting ongoing research into new therapeutic strategies and bioactive compounds with potential antitumor properties. In this context, apitherapy has attracted attention in biomedical research due to the presence of biologically active substances in bee products, particularly bee venom, propolis, and royal jelly. Several experimental studies have explored the potential anticancer activity of these compounds, mainly in cell culture and animal models.
One of the most extensively studied components in apitherapy is melittin, a peptide found in bee venom that has demonstrated the ability to induce apoptosis (programmed cell death) in certain cancer cell lines in laboratory studies. Additionally, some research suggests that melittin may interfere with mechanisms involved in tumor cell proliferation and angiogenesis. These findings have generated interest in the development of pharmacological strategies derived from bee venom components.
Propolis has also been widely investigated in cancer research. This bee product contains flavonoids, phenolic acids, and other compounds with antioxidant and anti-inflammatory properties that may influence cellular pathways involved in carcinogenesis. Experimental studies have shown that certain propolis components may modulate oxidative stress, cell proliferation, and signaling pathways associated with tumor development.
However, it is important to emphasize that most of the current scientific evidence regarding apitherapy and cancer comes from preclinical studies conducted in laboratory settings. Clinical trials in humans remain limited, and therefore apitherapy cannot currently be considered a treatment for cancer. In medical practice, the use of bee products in oncology should only be considered as a potential complementary approach within comprehensive care supervised by healthcare professionals.
| Cancer type | Type of research | Potential role of apitherapy |
|---|---|---|
| Breast cancer | Experimental (in vitro / animal) | Possible induction of apoptosis |
| Prostate cancer | Experimental | Potential antiproliferative effect |
| Lung cancer | Experimental | Possible modulation of inflammatory pathways |
| Colon cancer | Experimental | Possible antioxidant and cytotoxic effects |
| Melanoma | Experimental | Potential effect on tumor cell proliferation |
| Leukemia | Experimental | Possible induction of programmed cell death |
Is apitherapy safe? Risks, allergies, and medical considerations
Although apitherapy has been used for centuries in different medical traditions and is currently being investigated in scientific research, it is important to recognize that it is not free of risks. As with any therapeutic intervention involving biologically active substances, apitherapy should be applied cautiously and under the supervision of trained professionals. Patient safety remains a fundamental consideration when using bee-derived products in medical contexts.
One of the main risks associated with apitherapy is the possibility of allergic reactions to bee venom. Some individuals may develop intense local reactions, while in rare cases systemic reactions such as anaphylaxis may occur. For this reason, sensitivity or allergy testing is strongly recommended before initiating therapies that involve bee venom, along with the implementation of appropriate protocols for managing medical emergencies.
Another important consideration is the quality and origin of the products used in apitherapy. Bee products such as honey, propolis, and royal jelly can vary significantly in their chemical composition depending on botanical origin, processing methods, and storage conditions. To ensure safety and potential therapeutic effectiveness, it is advisable to use high-quality products obtained through responsible beekeeping practices and appropriate quality control.
It is also essential to emphasize that apitherapy should not replace conventional medical treatments, particularly in chronic or serious diseases. In the field of integrative medicine, apitherapy is generally explored as a complementary approach that may accompany evidence-based therapeutic strategies. Therefore, individuals interested in these therapies should seek guidance from qualified healthcare professionals before beginning treatment.
In summary, although apitherapy shows promising results in several research areas, its clinical application requires caution, individualized assessment, and medical supervision. Ongoing scientific research continues to clarify its potential benefits, as well as its risks and limitations.
What bee products are used in apitherapy?
Apitherapy involves the therapeutic use of several products derived from the beehive. Each of these substances contains bioactive compounds with biological properties that have been investigated in different fields of natural and integrative medicine. The most commonly studied bee products include honey, propolis, royal jelly, bee pollen, and bee venom.
Honey is one of the most widely recognized products in apitherapy. It contains natural sugars, enzymes, amino acids, and antioxidant compounds that have been investigated for their antimicrobial and anti-inflammatory properties. Some studies have explored its use in wound care, respiratory infections, and digestive disorders.
Propolis is another key substance used in apitherapy. Bees produce this resinous material from plant resins to protect the hive from microorganisms. Propolis contains flavonoids, phenolic acids, and other compounds with antioxidant, anti-inflammatory, and antimicrobial activity, which has led to its investigation in various inflammatory and infectious diseases.
Royal jelly is also an important component of apitherapy. Produced by worker bees, it is rich in proteins, B-complex vitamins, and unique bioactive compounds. Scientific studies have explored its potential influence on metabolic, immune, and antioxidant processes.
Bee pollen is another bee product frequently studied due to its nutritional profile, which includes proteins, vitamins, minerals, and antioxidant compounds. Some research has examined its possible role in nutritional support and inflammation modulation.
Finally, bee venom—also known as apitoxin—is one of the most studied elements in apitherapy. It contains several biologically active peptides, including melittin, which has been investigated for its potential anti-inflammatory, immunomodulatory, and analgesic properties. Due to its biological potency, bee venom therapy requires strict safety protocols and professional supervision.
Conclusion: the role of apitherapy in modern integrative medicine
Apitherapy represents a growing field of interest within natural medicine and biomedical research. Bee-derived products contain a wide range of bioactive compounds that have been investigated in multiple health conditions, including inflammatory, neurological, metabolic, digestive, and respiratory diseases.
Although promising findings have been reported in experimental studies and some clinical trials, the scientific evidence supporting apitherapy remains under development. Many studies are still preclinical or involve relatively small clinical samples, which limits definitive conclusions about their therapeutic effectiveness.
Within the framework of integrative medicine, apitherapy may be explored as a complementary approach that utilizes the biological properties of bee products alongside conventional medical treatments. Continued scientific research is essential to better understand the mechanisms of action, safety profile, and therapeutic potential of these natural compounds.
In the coming years, interest in apitherapy is likely to grow as researchers continue to investigate natural bioactive molecules and their potential role in future medical therapies. Advances in biomedical science may help identify specific compounds from bee products that could be developed into novel therapeutic agents.
Ultimately, apitherapy represents a promising area of natural medicine research, and its real clinical potential will become clearer as larger and more rigorous scientific studies are conducted.
References
Jagua-Gualdrón A, García-Reyes NA, Africano-Lopez HL. Apitherapy for drug-induced kidney disease: a narrative review on its mechanisms. J Complement Integr Med. 2025;22(2). doi:10.1515/jcim-2025-0082.
Jagua-Gualdrón A, García-Reyes NA, Fernández-Bernal RE. Apitherapy for diabetes mellitus: mechanisms and clinical implications. J Complement Integr Med. 2025;22(2):228-236. doi:10.1515/jcim-2024-0367.
Jagua-Gualdrón A. Apitherapy for osteoarthritis: perspectives from basic research. Complement Med Res. 2020;27(3):184-192. doi:10.1159/000505015.
Jagua-Gualdrón A. Cancer therapy with bee products: systematic review of experimental studies. Rev Fac Med (Bogotá). 2012;60(2):79-94.
Jagua-Gualdrón A. Medicina alternativa en el tratamiento de la osteoartrosis y artritis reumatoide: revisión sistemática de la literatura y metaanálisis. Rev Colomb Reumatol. 2012;19(4):234-244.
Wehbe R, Frangieh J, Rima M, El Obeid D, Sabatier JM, Fajloun Z. Bee venom: overview of main compounds and bioactivities for therapeutic interests. Molecules. 2019;24(16):2997.
Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev. 2017;2017:1259510.
Oršolić N. Bee venom in cancer therapy. Cancer Metastasis Rev. 2012;31(1-2):173-194.
Kocot J, Kiełczykowska M, Luchowska-Kocot D, Kurzepa J, Musik I. Antioxidant potential of propolis, bee pollen and royal jelly: possible medical application. Oxid Med Cell Longev. 2018;2018:7074209.
Bogdanov S, Jurendic T, Sieber R, Gallmann P. Honey for nutrition and health: a review. J Am Coll Nutr. 2008;27(6):677-689.
About the Author
Dr. Andrés Jagua-Gualdrón
Physician – Apitherapy Specialist
Director, International Institute of Alternative and Natural Medicine (IIMAN)
Dr. Andrés Jagua-Gualdrón is a physician and apitherapy specialist with extensive clinical and scientific experience in the therapeutic use of bee products. He serves as Director of the International Institute of Alternative and Natural Medicine (IIMAN), where he leads research and professional training initiatives focused on evidence-based natural therapies.
He is also a scientific communicator and international lecturer, recognized for his work in promoting apitherapy as a complementary therapeutic approach supported by clinical and biomedical research.
